microarray gene expression analyses
(Illumina Inc)
Illumina Inc is a verified supplier
Structured Review
Illumina Inc
microarray gene expression analyses
Microarray Gene Expression Analyses, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/product/gene+expression+microarray+analyses/gene+expression+data/pmc04536321-93-15-14
Average 90 stars, based on 1 article reviews
microarray gene expression analyses - by
Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Divergent target recognition by coexpressed 5′-isomiRs of miR-142-3p and selective viral mimicry"
Article Title: Divergent target recognition by coexpressed 5′-isomiRs of miR-142-3p and selective viral mimicry
Journal: RNA
doi: 10.1261/rna.048876.114
Figure Legend Snippet: Target recognition by the miR-142-3p/−1 and miR-K10a/+1 5′-isomiRs. ( A , B ) Overlap of binding sites for the miR-142-3p and miR-K10a 5′-isomiRs identified in Ago2-PAR-CLIP data from ( A ) BC-1 and ( B ) BC-3 PEL cell lines . ( C ) Minimum base-pairing required for the miR-142-3p ( upper panel) and miR-K10a ( lower panel) 5′-isomiRs to share canonical binding sites. ( D ) Principal component analysis of microarray data of HEK293T cells transfected with individual 5′-isomiRs. ( E – I ) Sylamer enrichment landscape plots for 7mer 3′-UTR matches to miR-142-3p and miR-K10a 5′-isomiRs using microarray data from 293T cells transfected with individual miRNA mimics ( E – H , this study) or from published microarray data from miR-142 −/− mouse megakaryocytes (GEO data set GSE52141, ). The x -axis represents the ranked gene lists. miR-155 sites (pink and black lines) served as negative controls in addition to all random 7mers (gray). Enrichment plots for hexamer motifs are shown in Supplemental Figure S2.
Techniques Used: Binding Assay, Microarray, Transfection
Related Articles
Generated:
Gene Expression:
Article Title: Whole-cell cancer vaccines and methods for selection thereof
Article Snippet: .. Furthermore, even though SV-BR-1-GM cells were engineered to express CSF2 (i.e., which encodes GM-CSF), CSF2 transcripts were not detected by Illumina® microarray gene expression profiling. .. Furthermore, even though SV-BR-1-GM cells were engineered to express CSF2 (i.e., which encodes GM-CSF), CSF2 transcripts were not detected by Illumina microarray gene expression profiling.
Article Title: FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
Article Snippet: .. Accession Number Platform Number of Patients Male (%) Age (mean ±sd) Fuhrm an (1/2/3/ 4) Grade (G1/G2/ G3/G4) Stage (I/II/III/ IV) Survival Data TCGA- KIRC Illumina HiSeq 2000 RNA Sequencing V2 530 64.91 60.56± 12.14 NA 14/230/20 7/78 269/57/1 25/83 OS E-MTAB- 1980 Agilent Human Gene Expression 4x44K v2 Microarray 026652 G4845A 101 76.24 63.48± 11.50 13/59/ 22/5 NA NA OS/MFS GSE781 Affymetrix Human Genome U133B Array 12 75 62.33± 7.36 4/2/3/0 NA NA NA GSE6344 Affymetrix Human Genome U133B Array 10 NA NA NA NA NA NA GSE14762 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array [MBNI v6 Entrez Gene ID CDF] 10 NA NA NA NA NA NA GSE17895 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array (MBNI v11 Entrez Gene ID CDF) 138 NA NA NA NA NA NA GSE36895 Affymetrix Human Genome U133 Plus 2.0 Array 29 58.62 63.25± 14.19 2/13/6/ 8 NA 5/2/3/6 NA GSE40435 Illumina HumanHT-12 V4.0 expression beadchip 101 58.42 64.11± 9.19 NA NA 14/27/13 /5 NA GSE46699 Affymetrix Human Genome U133 Plus 2.0 Array 67 NA NA NA NA NA NA GSE53000 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 53 64.15 61.66± 9.02 NA NA NA NA GSE53757 Affymetrix Human Genome U133 Plus 2.0 Array 72 NA NA NA NA 24/19/14 /15 NA GSE66272 Affymetrix Human Genome U133 Plus 2.0 Array 27 70.37 64.22± NA 1/16/8/2 NA NA 9.19 GSE68417 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 29 NA NA 2/11/1 4/2 NA NA NA GSE71963 Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) 32 NA NA NA NA NA NA GSE73731 Affymetrix Human Genome U133 Plus 2.0 Array 265 61.07 NA NA 22/90/95/ 49 41/12/28 /44 NA GSE105261 Illumina HumanHT-12 V4.0 expression beadchip 9 NA NA NA NA NA NA GSE126964 HiSeq X Ten (Homo sapiens) 55 74.55 58.36± 10.15 NA 4/21/12/3 NA NA GSE150404 Affymetrix Human Gene 2.1 ST Array [transcript (gene) version] 60 48.28 62.08± 7.43 NA NA 15/15/15 /15 NA Table S2 The target sequence of sh-ZIC2 and sh-FOXM1. ..
Microarray:
Article Title: Whole-cell cancer vaccines and methods for selection thereof
Article Snippet: .. Furthermore, even though SV-BR-1-GM cells were engineered to express CSF2 (i.e., which encodes GM-CSF), CSF2 transcripts were not detected by Illumina® microarray gene expression profiling. .. Furthermore, even though SV-BR-1-GM cells were engineered to express CSF2 (i.e., which encodes GM-CSF), CSF2 transcripts were not detected by Illumina microarray gene expression profiling.
Article Title: FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
Article Snippet: .. Accession Number Platform Number of Patients Male (%) Age (mean ±sd) Fuhrm an (1/2/3/ 4) Grade (G1/G2/ G3/G4) Stage (I/II/III/ IV) Survival Data TCGA- KIRC Illumina HiSeq 2000 RNA Sequencing V2 530 64.91 60.56± 12.14 NA 14/230/20 7/78 269/57/1 25/83 OS E-MTAB- 1980 Agilent Human Gene Expression 4x44K v2 Microarray 026652 G4845A 101 76.24 63.48± 11.50 13/59/ 22/5 NA NA OS/MFS GSE781 Affymetrix Human Genome U133B Array 12 75 62.33± 7.36 4/2/3/0 NA NA NA GSE6344 Affymetrix Human Genome U133B Array 10 NA NA NA NA NA NA GSE14762 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array [MBNI v6 Entrez Gene ID CDF] 10 NA NA NA NA NA NA GSE17895 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array (MBNI v11 Entrez Gene ID CDF) 138 NA NA NA NA NA NA GSE36895 Affymetrix Human Genome U133 Plus 2.0 Array 29 58.62 63.25± 14.19 2/13/6/ 8 NA 5/2/3/6 NA GSE40435 Illumina HumanHT-12 V4.0 expression beadchip 101 58.42 64.11± 9.19 NA NA 14/27/13 /5 NA GSE46699 Affymetrix Human Genome U133 Plus 2.0 Array 67 NA NA NA NA NA NA GSE53000 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 53 64.15 61.66± 9.02 NA NA NA NA GSE53757 Affymetrix Human Genome U133 Plus 2.0 Array 72 NA NA NA NA 24/19/14 /15 NA GSE66272 Affymetrix Human Genome U133 Plus 2.0 Array 27 70.37 64.22± NA 1/16/8/2 NA NA 9.19 GSE68417 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 29 NA NA 2/11/1 4/2 NA NA NA GSE71963 Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) 32 NA NA NA NA NA NA GSE73731 Affymetrix Human Genome U133 Plus 2.0 Array 265 61.07 NA NA 22/90/95/ 49 41/12/28 /44 NA GSE105261 Illumina HumanHT-12 V4.0 expression beadchip 9 NA NA NA NA NA NA GSE126964 HiSeq X Ten (Homo sapiens) 55 74.55 58.36± 10.15 NA 4/21/12/3 NA NA GSE150404 Affymetrix Human Gene 2.1 ST Array [transcript (gene) version] 60 48.28 62.08± 7.43 NA NA 15/15/15 /15 NA Table S2 The target sequence of sh-ZIC2 and sh-FOXM1. ..
RNA Sequencing:
Article Title: FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
Article Snippet: .. Accession Number Platform Number of Patients Male (%) Age (mean ±sd) Fuhrm an (1/2/3/ 4) Grade (G1/G2/ G3/G4) Stage (I/II/III/ IV) Survival Data TCGA- KIRC Illumina HiSeq 2000 RNA Sequencing V2 530 64.91 60.56± 12.14 NA 14/230/20 7/78 269/57/1 25/83 OS E-MTAB- 1980 Agilent Human Gene Expression 4x44K v2 Microarray 026652 G4845A 101 76.24 63.48± 11.50 13/59/ 22/5 NA NA OS/MFS GSE781 Affymetrix Human Genome U133B Array 12 75 62.33± 7.36 4/2/3/0 NA NA NA GSE6344 Affymetrix Human Genome U133B Array 10 NA NA NA NA NA NA GSE14762 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array [MBNI v6 Entrez Gene ID CDF] 10 NA NA NA NA NA NA GSE17895 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array (MBNI v11 Entrez Gene ID CDF) 138 NA NA NA NA NA NA GSE36895 Affymetrix Human Genome U133 Plus 2.0 Array 29 58.62 63.25± 14.19 2/13/6/ 8 NA 5/2/3/6 NA GSE40435 Illumina HumanHT-12 V4.0 expression beadchip 101 58.42 64.11± 9.19 NA NA 14/27/13 /5 NA GSE46699 Affymetrix Human Genome U133 Plus 2.0 Array 67 NA NA NA NA NA NA GSE53000 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 53 64.15 61.66± 9.02 NA NA NA NA GSE53757 Affymetrix Human Genome U133 Plus 2.0 Array 72 NA NA NA NA 24/19/14 /15 NA GSE66272 Affymetrix Human Genome U133 Plus 2.0 Array 27 70.37 64.22± NA 1/16/8/2 NA NA 9.19 GSE68417 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 29 NA NA 2/11/1 4/2 NA NA NA GSE71963 Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) 32 NA NA NA NA NA NA GSE73731 Affymetrix Human Genome U133 Plus 2.0 Array 265 61.07 NA NA 22/90/95/ 49 41/12/28 /44 NA GSE105261 Illumina HumanHT-12 V4.0 expression beadchip 9 NA NA NA NA NA NA GSE126964 HiSeq X Ten (Homo sapiens) 55 74.55 58.36± 10.15 NA 4/21/12/3 NA NA GSE150404 Affymetrix Human Gene 2.1 ST Array [transcript (gene) version] 60 48.28 62.08± 7.43 NA NA 15/15/15 /15 NA Table S2 The target sequence of sh-ZIC2 and sh-FOXM1. ..
other:
Article Title: Identifying the importance of PCK1 in maintaining ileal epithelial barrier integrity in Crohn's disease.
Article Snippet: Single-cell RNA-sequencing (scRNA-seq) data from GSE134809 (Martin et al., 2019) (performed on Illumina NextSeq 500) and microarray data from GSE69762 (Hayashi et al., 2016), GSE75214 (Vancamelbeke et al., 2017) (both conducted using Affymetrix Human Gene 1.0 ST Array), and GSE179285 (Keir et al., 2021) (carried out using Agilent-014850 Whole Human Genome Microarray 4x44K G4112F) were obtained from the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/).
Expressing:Article Title: FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
Article Snippet: .. Accession Number Platform Number of Patients Male (%) Age (mean ±sd) Fuhrm an (1/2/3/ 4) Grade (G1/G2/ G3/G4) Stage (I/II/III/ IV) Survival Data TCGA- KIRC Illumina HiSeq 2000 RNA Sequencing V2 530 64.91 60.56± 12.14 NA 14/230/20 7/78 269/57/1 25/83 OS E-MTAB- 1980 Agilent Human Gene Expression 4x44K v2 Microarray 026652 G4845A 101 76.24 63.48± 11.50 13/59/ 22/5 NA NA OS/MFS GSE781 Affymetrix Human Genome U133B Array 12 75 62.33± 7.36 4/2/3/0 NA NA NA GSE6344 Affymetrix Human Genome U133B Array 10 NA NA NA NA NA NA GSE14762 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array [MBNI v6 Entrez Gene ID CDF] 10 NA NA NA NA NA NA GSE17895 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array (MBNI v11 Entrez Gene ID CDF) 138 NA NA NA NA NA NA GSE36895 Affymetrix Human Genome U133 Plus 2.0 Array 29 58.62 63.25± 14.19 2/13/6/ 8 NA 5/2/3/6 NA GSE40435 Illumina HumanHT-12 V4.0 expression beadchip 101 58.42 64.11± 9.19 NA NA 14/27/13 /5 NA GSE46699 Affymetrix Human Genome U133 Plus 2.0 Array 67 NA NA NA NA NA NA GSE53000 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 53 64.15 61.66± 9.02 NA NA NA NA GSE53757 Affymetrix Human Genome U133 Plus 2.0 Array 72 NA NA NA NA 24/19/14 /15 NA GSE66272 Affymetrix Human Genome U133 Plus 2.0 Array 27 70.37 64.22± NA 1/16/8/2 NA NA 9.19 GSE68417 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 29 NA NA 2/11/1 4/2 NA NA NA GSE71963 Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) 32 NA NA NA NA NA NA GSE73731 Affymetrix Human Genome U133 Plus 2.0 Array 265 61.07 NA NA 22/90/95/ 49 41/12/28 /44 NA GSE105261 Illumina HumanHT-12 V4.0 expression beadchip 9 NA NA NA NA NA NA GSE126964 HiSeq X Ten (Homo sapiens) 55 74.55 58.36± 10.15 NA 4/21/12/3 NA NA GSE150404 Affymetrix Human Gene 2.1 ST Array [transcript (gene) version] 60 48.28 62.08± 7.43 NA NA 15/15/15 /15 NA Table S2 The target sequence of sh-ZIC2 and sh-FOXM1. ..
Sequencing:Article Title: FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway
Article Snippet: .. Accession Number Platform Number of Patients Male (%) Age (mean ±sd) Fuhrm an (1/2/3/ 4) Grade (G1/G2/ G3/G4) Stage (I/II/III/ IV) Survival Data TCGA- KIRC Illumina HiSeq 2000 RNA Sequencing V2 530 64.91 60.56± 12.14 NA 14/230/20 7/78 269/57/1 25/83 OS E-MTAB- 1980 Agilent Human Gene Expression 4x44K v2 Microarray 026652 G4845A 101 76.24 63.48± 11.50 13/59/ 22/5 NA NA OS/MFS GSE781 Affymetrix Human Genome U133B Array 12 75 62.33± 7.36 4/2/3/0 NA NA NA GSE6344 Affymetrix Human Genome U133B Array 10 NA NA NA NA NA NA GSE14762 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array [MBNI v6 Entrez Gene ID CDF] 10 NA NA NA NA NA NA GSE17895 Affymetrix GeneChip Human Genome U133 Plus 2.0 Array (MBNI v11 Entrez Gene ID CDF) 138 NA NA NA NA NA NA GSE36895 Affymetrix Human Genome U133 Plus 2.0 Array 29 58.62 63.25± 14.19 2/13/6/ 8 NA 5/2/3/6 NA GSE40435 Illumina HumanHT-12 V4.0 expression beadchip 101 58.42 64.11± 9.19 NA NA 14/27/13 /5 NA GSE46699 Affymetrix Human Genome U133 Plus 2.0 Array 67 NA NA NA NA NA NA GSE53000 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 53 64.15 61.66± 9.02 NA NA NA NA GSE53757 Affymetrix Human Genome U133 Plus 2.0 Array 72 NA NA NA NA 24/19/14 /15 NA GSE66272 Affymetrix Human Genome U133 Plus 2.0 Array 27 70.37 64.22± NA 1/16/8/2 NA NA 9.19 GSE68417 Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] 29 NA NA 2/11/1 4/2 NA NA NA GSE71963 Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) 32 NA NA NA NA NA NA GSE73731 Affymetrix Human Genome U133 Plus 2.0 Array 265 61.07 NA NA 22/90/95/ 49 41/12/28 /44 NA GSE105261 Illumina HumanHT-12 V4.0 expression beadchip 9 NA NA NA NA NA NA GSE126964 HiSeq X Ten (Homo sapiens) 55 74.55 58.36± 10.15 NA 4/21/12/3 NA NA GSE150404 Affymetrix Human Gene 2.1 ST Array [transcript (gene) version] 60 48.28 62.08± 7.43 NA NA 15/15/15 /15 NA Table S2 The target sequence of sh-ZIC2 and sh-FOXM1. ..
|